Lancaster city is ready to begin the final phases of a water transmission system overhaul that will cost tens of millions of dollars and likely disrupt traffic in ...

Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early next year. The Danish pharma and obesity heavyweight is moving forward ...

President Donald Trump said plans are in place for a FEMA phase out by end of the 2025 hurricane season.

Vietnam has formally launched the pilot phase of an emissions trading scheme aimed at encouraging three major industrial sectors to cut the amount of carbon dioxide they produce, the government ...

In a sign of China's accelerating ambitions in the semiconductor race, ChangXin Memory Technologies (CXMT), the country's leading DRAM manufacturer, is rapidly advancing development of next ...

President Donald Trump said Tuesday that he plans to phase out the Federal Emergency Management Agency after this year’s hurricane season, offering the clearest timeline yet for his ...

With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 ...

A 12-week Phase 1 study evaluating the combination of this drug with Metsera’s amylin drug candidate is underway; preliminary data are expected by the end of this year or in early 2026.

Cleveland Hopkins International Airport opened bidding for first stage of $1.1-billion airport expansion and modernization. The lead architect is Corgan and engineering consultant is Connico.

ROSELLA: A phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in patients with platinum-resistant ovarian cancer (GOG-3073, ENGOT-ov72).

According to a filing with the state, the layoffs will occur in phases, starting on August 1, with the final round of layoffs expected by March of 2026.

Your first introduction to AI probably resulted in an indifferent grunt. But now, it's reshaping your sales day. In this column, Bill Farquharson charts the journey from skepticism to full-on AI ...